F-FDG PET/CT showed moderate radiopharmaceutical uptake corresponding to the paravertebral lesion (SUVmax 3.3) and diffuse uptake in the skeleton suspicious for bone marrow neoplastic involvement, with more evident hypermetabolic areas in the left scapula (SUVmax 3.7), right sixth rib (SUVmax 3.5), and left iliac bone (SUVmax 3.4) (Fig. 1) . Subsequent bone marrow biopsy confirmed the bone marrow infiltration by plasmablastic cells.
Based on these findings, a final diagnosis of plasmablastic lymphoma with bone marrow involvement was performed and the patient was addressed to chemotherapy.
Plasmablastic lymphoma is a rare CD20-negative large-cell lymphoma with plasmablastic features occurring primarily in HIVor Epstein-Barr virus positive individuals. Distinguishing this tumor from myeloma could be challenging [1] [2] [3] . The most frequent site of presentation is the oral cavity, whereas extraoral localizations of plasmablastic lymphoma are considered to be very rare [1] [2] [3] and they should be differentiated from extraosseous localization of multiple myeloma or plasma cell leukemia which have similar characteristics at 18 F-FDG PET/CT [4, 5] . In our case 18 F-FDG PET/CT has been very useful in the disease assessment of this rare tumor with an atypical presentation.
